109 related articles for article (PubMed ID: 10799328)
1. ATP hydrolysis by a CFTR domain: pharmacology and effects of G551D mutation.
Howell LD; Borchardt R; Cohn JA
Biochem Biophys Res Commun; 2000 May; 271(2):518-25. PubMed ID: 10799328
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
[TBL] [Abstract][Full Text] [Related]
3. Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
Basso C; Vergani P; Nairn AC; Gadsby DC
J Gen Physiol; 2003 Sep; 122(3):333-48. PubMed ID: 12939393
[TBL] [Abstract][Full Text] [Related]
4. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains.
Vergani P; Lockless SW; Nairn AC; Gadsby DC
Nature; 2005 Feb; 433(7028):876-80. PubMed ID: 15729345
[TBL] [Abstract][Full Text] [Related]
5. Domain-domain associations in cystic fibrosis transmembrane conductance regulator.
Wang W; He Z; O'Shaughnessy TJ; Rux J; Reenstra WW
Am J Physiol Cell Physiol; 2002 May; 282(5):C1170-80. PubMed ID: 11940532
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of the NBD1-R domain region of CFTR: evidence for subunit-subunit interactions.
Neville DC; Rozanas CR; Tulk BM; Townsend RR; Verkman AS
Biochemistry; 1998 Feb; 37(8):2401-9. PubMed ID: 9485388
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator.
Ketchum CJ; Rajendrakumar GV; Maloney PC
Biochemistry; 2004 Feb; 43(4):1045-53. PubMed ID: 14744150
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator, an ABC transporter, catalyze adenylate kinase activity but not ATP hydrolysis.
Gross CH; Abdul-Manan N; Fulghum J; Lippke J; Liu X; Prabhakar P; Brennan D; Willis MS; Faerman C; Connelly P; Raybuck S; Moore J
J Biol Chem; 2006 Feb; 281(7):4058-68. PubMed ID: 16361259
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis transmembrane conductance regulator: the NBF1+R (nucleotide-binding fold 1 and regulatory domain) segment acting alone catalyses a Co2+/Mn2+/Mg2+-ATPase activity markedly inhibited by both Cd2+ and the transition-state analogue orthovanadate.
Annereau JP; Ko YH; Pedersen PL
Biochem J; 2003 Apr; 371(Pt 2):451-62. PubMed ID: 12523935
[TBL] [Abstract][Full Text] [Related]
10. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
[TBL] [Abstract][Full Text] [Related]
11. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.
Pasyk S; Li C; Ramjeesingh M; Bear CE
Biochem J; 2009 Feb; 418(1):185-90. PubMed ID: 18945216
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog.
Bompadre SG; Li M; Hwang TC
J Biol Chem; 2008 Feb; 283(9):5364-9. PubMed ID: 18167357
[TBL] [Abstract][Full Text] [Related]
13. The cystic fibrosis mutation G551D alters the non-Michaelis-Menten behavior of the cystic fibrosis transmembrane conductance regulator (CFTR) channel and abolishes the inhibitory Genistein binding site.
Derand R; Bulteau-Pignoux L; Becq F
J Biol Chem; 2002 Sep; 277(39):35999-6004. PubMed ID: 12124395
[TBL] [Abstract][Full Text] [Related]
14. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
Csanády L; Chan KW; Nairn AC; Gadsby DC
J Gen Physiol; 2005 Jan; 125(1):43-55. PubMed ID: 15596536
[TBL] [Abstract][Full Text] [Related]
15. Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator.
Lewis HA; Buchanan SG; Burley SK; Conners K; Dickey M; Dorwart M; Fowler R; Gao X; Guggino WB; Hendrickson WA; Hunt JF; Kearins MC; Lorimer D; Maloney PC; Post KW; Rajashankar KR; Rutter ME; Sauder JM; Shriver S; Thibodeau PH; Thomas PJ; Zhang M; Zhao X; Emtage S
EMBO J; 2004 Jan; 23(2):282-93. PubMed ID: 14685259
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis transmembrane conductance regulator: the purified NBF1+R protein interacts with the purified NBF2 domain to form a stable NBF1+R/NBF2 complex while inducing a conformational change transmitted to the C-terminal region.
Lu NT; Pedersen PL
Arch Biochem Biophys; 2000 Mar; 375(1):7-20. PubMed ID: 10683244
[TBL] [Abstract][Full Text] [Related]
17. Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop.
Ehrhardt A; Chung WJ; Pyle LC; Wang W; Nowotarski K; Mulvihill CM; Ramjeesingh M; Hong J; Velu SE; Lewis HA; Atwell S; Aller S; Bear CE; Lukacs GL; Kirk KL; Sorscher EJ
J Biol Chem; 2016 Jan; 291(4):1854-1865. PubMed ID: 26627831
[TBL] [Abstract][Full Text] [Related]
18. A heteromeric complex of the two nucleotide binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) mediates ATPase activity.
Kidd JF; Ramjeesingh M; Stratford F; Huan LJ; Bear CE
J Biol Chem; 2004 Oct; 279(40):41664-9. PubMed ID: 15284228
[TBL] [Abstract][Full Text] [Related]
19. On the mechanism of MgATP-dependent gating of CFTR Cl- channels.
Vergani P; Nairn AC; Gadsby DC
J Gen Physiol; 2003 Jan; 121(1):17-36. PubMed ID: 12508051
[TBL] [Abstract][Full Text] [Related]
20. Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1.
Yang Z; Hildebrandt E; Jiang F; Aleksandrov AA; Khazanov N; Zhou Q; An J; Mezzell AT; Xavier BM; Ding H; Riordan JR; Senderowitz H; Kappes JC; Brouillette CG; Urbatsch IL
Biochim Biophys Acta Biomembr; 2018 May; 1860(5):1193-1204. PubMed ID: 29425673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
